Skip to main content

Supply Chain

By Susan Morse | 09:02 am | July 16, 2015
Group purchasing saves Kansas Hospital Association members up to 50 percent on natural gas contracts, 11 percent on air gas renewal, over 50 percent in radiology procedure supplies and realized a 5 to 12 percent reduction in the cost of facilities and construction.
By Chuck Green | 08:20 am | July 16, 2015
Declines in inpatient volume, reimbursement and changes in the boundary between payers and providers are compelling CFOs across the country to develop new, innovative ways to cut costs.
By Henry Powderly | 10:10 am | July 07, 2015
Harvard Drug Group mainly distributes generic pharmaceuticals and pulled in more than $450 million in revenue in fiscal 2014.
By Henry Powderly | 11:11 am | July 01, 2015
According to tax and advisory firm KPMG, 74 percent of healthcare providers say they are either in the beginning stages or have not even begun to invest is systems for analytics and financial reporting.
By Henry Powderly | 09:58 am | July 01, 2015
Major cancer centers topped the list with tens of millions in payments and services from pharmaceutical giants.
By Henry Powderly | 04:06 pm | June 30, 2015
Several teaching hospitals raked millions in payments from device and drug manufacturers in 2014, according to new data from the Centers for Medicare and Medicaid Services released Tuesday that showed drug and medical device makers made close to $6.5 billion in payments to healthcare providers in 2014.
By Kaiser Health News | 08:11 am | June 16, 2015
Nearly three in four Americans say the costs of prescription drugs are "unreasonable," with most putting the blame on drugmakers, a survey by the Kaiser Family Foundation found.
By Susan Morse | 01:52 pm | March 23, 2015
The privately held company is in the $9 billion global market for products designed for the treatment of vertebral compression fractures, degenerative disc disease.
By Chuck Green | 08:31 am | March 23, 2015
Hospital chief financial officers have indispensable business intelligence towards managing costs surrounding supply chain purchases.
By Henry Powderly | 09:36 am | March 18, 2015
Actavis said the newly combined company, which will take on the Allergan name, is expected to net $23 billion in sales in 2015.